Inspire Medical Systems (INSP) Net Equity Issued and Repurchased (2018)
Inspire Medical Systems' (INSP) quarterly Net Equity Issued and Repurchased came in at $69.8 million in Q4 2018, up 6978200.0% quarter-over-quarter from $1000.0 in Q3 2018.
Analysis
Inspire Medical Systems (INSP) Net Equity Issued and Repurchased (2018) Analysis & Trends
Inspire Medical Systems has disclosed Net Equity Issued and Repurchased across 1 years of filings, most recently posting $69.8 million for Q4 2018.
- In Q4 2018, Net Equity Issued and Repurchased changed N/A year-over-year to $69.8 million; the TTM figure through Sep 2020 stood at $69.8 million (changed 0.0% YoY), while the FY2022 annual figure was $243.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at $69.8 million for Q4 2018 at Inspire Medical Systems, up from $1000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $69.8 million in Q4 2018 to a low of $1000.0 in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Inspire Medical Systems | 1.82 Bn | 1.50 Bn | 171.46 Mn | - |